Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mängden CD163 positiva makrofager och tumör infiltrerande lymfocyter i bröstkarcinom kan eventuellt påverka effekten av behandling med epirubicin och docetaxel.
Karlstad University, Faculty of Health, Science and Technology (starting 2013), Department of Health Sciences.
2017 (Swedish)Independent thesis Basic level (degree of Bachelor), 10 credits / 15 HE creditsStudent thesisAlternative title
The amount of CD163 positive macrophages and tumor infiltrating lymphocytes in breast carcinoma could possibly affect the treatment with epirubicin and docetaxel (English)
Place, publisher, year, edition, pages
2017.
National Category
Biomedical Laboratory Science/Technology
Identifiers
URN: urn:nbn:se:kau:diva-64559OAI: oai:DiVA.org:kau-64559DiVA: diva2:1146942
Available from: 2017-10-04 Created: 2017-10-04 Last updated: 2017-10-04Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Health Sciences
Biomedical Laboratory Science/Technology

Search outside of DiVA

GoogleGoogle Scholar

Total: 4 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf